Martis Capital, a middle-market private equity firm focused exclusively on the healthcare industry, is pleased to commence 2026 with three investment team promotions. Phil Campbell and David Zhang have been promoted from Director to Principal, and Jack Stoney from Senior Associate to Vice President.
Based in Washington, DC, Phil joined Martis in 2016 and helps lead the firm’s investments in Amivie, Hospice Care, and ShareMD, among others. Phil had also been previously involved in other successful exits like Care Hospice and Centria Healthcare. Prior to Martis, he worked at CIT Group and HJ Sims, with a focus on healthcare.
Based in San Francisco, CA, David joined Martis in 2020 and helps lead the firm’s investments in Alcanza Clinical Research and Rise Health. He started his career at Barclays, then focused on middle-market buyout investing at Welsh, Carson, Anderson & Stowe and Calera Capital.
Based in Miami, FL, Jack joined Martis in 2020 and helps lead the firm’s investments in Alcanza Clinical Research and Lighthouse Lab Services, among others. Prior to Martis, he worked at Coker Capital Advisors.
“We’re excited to announce the promotions of Phil, David, and Jack”, said Mario Moreno, Managing Partner at Martis Capital. “Their contributions within Martis and their support across our portfolio companies have been critical to our firm’s success.”
About Martis Capital
Based in San Francisco, Washington, DC and Miami, Martis Capital is a founder-friendly capital partner for growth-oriented healthcare companies. Since 2011, Martis Capital has raised more than $2.2 billion from a global base of institutional clients to invest in the middle-market North American healthcare sector. For more information, visit www.martiscapital.com.
